AdvisorNet Financial, Inc - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 132 filers reported holding TG THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$33,000
+32.0%
3,000
-33.3%
0.00%
+50.0%
Q3 2019$25,000
-28.6%
4,500
+12.5%
0.00%
-50.0%
Q2 2019$35,000
+2.9%
4,000
-5.9%
0.00%0.0%
Q1 2019$34,000
+161.5%
4,250
+30.8%
0.00%
+100.0%
Q4 2018$13,000
-43.5%
3,250
-20.2%
0.00%
-33.3%
Q3 2018$23,000
+475.0%
4,075
+1258.3%
0.00%
+200.0%
Q2 2018$4,0003000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders